GLAXOSMITHKLINE PLC-SPON ADR

GSK stock holders 13F

2 superinvestors reported owning GSK (ADR) according to the gurus' 2022 Q3 reports.

Top 2 gurus who own (GSK) GLAXOSMITHKLINE PLC-SPON ADR

The 2 super investors (holders) owning GSK (by the percentage (%) of portfolio) are Thomas Graham, Alan, Irving Kahns - Kahn Brothers Group (5.98%) and B. Tweedy, Ch. Browne - Tweedy, Browne Co All Funds (US) (0.19%) as of their 2022 Q3 reports.

To check the latest activities of the top GSK shareholders between value investors, please click on the "Activity" tab.

To see the historical data of GSK's holders please click on the "2022 Q3" dropdown menu and select the date.

# of holders: 2
Period: 2022 Q3
Type: ADR
History
Name
Company
% of
Portfolio
Shares*
Price*
Value
% (shares)
Activity
% change to
Portfolio
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
0.19%
145,663
$29.43
$4,287,000
-4.38% (-6,674)
-0.01%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
5.98%
1,304,939
$29.43
$38,404,190
+13.98% (+160,011)
+0.73%
Current price: $33.96 15.39% AVG reported hold price*: $29.43

Completely sold out

History
Name
Company
Sold
Shares*
% change to
Portfolio
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
20,961,478
-2.87%
Mark A. Hillman
Hillman Value Fund
128,000
-3.87%

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.